SERPINA1 and alpha 1-antitrypsin deficiency: Consequently, important health organizations such as the World Health Organization, the American Thoracic Society, or the European Respiratory Society strongly advise determining plasmatic AAT concentration in COPD and other AATD-associated conditions [14,15,16].